期刊文献+

某省20~65周岁已婚妇女宫颈癌及癌前病变发病率的贝叶斯估计 被引量:5

Bayesian estimation of incidences of cervical carcinoma and cervical precancerous lesion in women aged 20 to 65 years in a given province
下载PDF
导出
摘要 目的:估计某省宫颈癌癌前病变CINII°及以上(CINIII°、宫颈癌)的发病率,并为宫颈癌的防治提供依据。方法:对该省20—65周岁已婚妇女进行宫颈癌筛查,并对部分筛查正常者隔年随访,通过贝叶斯方法估计发病情况。结果:共进行113134例。累计226972.33人年随访,其中1846例细胞学阳性需进行病理学检查,最终收到1510份病理结果,检出CINII°及以上者442例;通过贝叶斯法考虑病理检查随访人群中的失访病例以及细胞学检查阴性人群中的漏诊病例,估计得该省宫颈癌癌前病变CINII°及以上的发病率为283.79/10万,95%可信区间(201.58,393.06)/10万。结论:基于贝叶斯法,考虑了病理检查失访人群中的失访病例以及细胞学检查阴性人群中的漏诊病例,估计得到的该省宫颈癌癌前病变CINII°及以上的发病率更合理、更准确。 Objective : To estimate the incidences of cervical intraepithelial neoplasia (CIN) II or worse ( CIN III, cervical carcinoma) in a given province, and to provide the basis for the prevention and treatment of cervical cancer. Methods: Mar- ried women aged 20 - 65 years in the province accepted cervical cancer screening, and those with normal screening results were followed - up every other year. The incidences of CIN II or worse in the province were estimated with Bayesian method. Results : A total of 113 134 women were followed up for 226 972.33 person - year totally. In addition, 1846 women with posi- tive cytology experienced cervical histopathological examinations, and 1510 pathologic diagnoses were obtained finally. A total of 442 cases of CIN II or worse were detected. The incidences of CIN II or worse was 283.79/100 thousand, and 95% confi- dence interval (CI) was calculated as (201.58,393.06)/100 thousand. Conclusion: Considering the follow - up failing eases in the pathologic examinations and the missed cases in the negative cytology diagnoses of the subjects, the incidence of CIN II or worse should be more reasonable and accurate, if it is based on the Bayesian method.
出处 《中国计划生育学杂志》 2013年第12期796-799,共4页 Chinese Journal of Family Planning
基金 江苏省科技支撑计划(社会发展)项目(BS2007080)
关键词 癌前病变 宫颈癌 发病率 贝叶斯 Precancerous lesion Cervical carcinoma Incidence Bayesian
  • 相关文献

参考文献11

  • 1Arbyn M, Castellsague X, de Sanjose S, et al. Worldwide burden of cervical cancer in 2008 [ J ]. Ann Oncol, 2011,22 ( 12 ) : 2675 - 2686.
  • 2Shi JF, Canfell K, Lew JB, et al. The burden of cervical cancer in China : synthesis of the evidence [ J ]. Int J Cancer, 2012,130 ( 3 ) : 641 - 652.
  • 3陈汉明.宫颈癌危险因素调查分析[J].现代医院,2011,11(1):44-45. 被引量:16
  • 4Richart RM. A modified terminology for cervical intraepithelial neo- plasia[ J ]. Obstet Gynecol, 1990,75 ( 1 ) : 131 - 133.
  • 5葛爱华,魏永越,李瑛,吴玉麟,彭志行,潘丽,张肖敏,陈峰.大型流行病学调查资料的数据管理和质量控制[J].南京医科大学学报(自然科学版),2011,31(4):544-548. 被引量:9
  • 6Joseph L, Gyorkos TW, Coupal L. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard [ J ]. Am J Epidemiol, 1995,141 ( 3 ) :263 - 272.
  • 7Basanez MG, Marshall C, Carabin H, et al. Bayesian statistics for parasitologists [ J ]. Trends Parasitol, 2004,20 ( 2 ) : 85 - 91.
  • 8Efron B. Bayesians, Frequentists and Scientists [ M ] : Journal of the American Statistical Association ,2005 : 100,469.
  • 9王小峰,陈炳为,刘沛.无金标准诊断实验条件下贝叶斯先验参数的确定方法及SAS实现[J].中国卫生统计,2007,24(3):232-234. 被引量:7
  • 10Arbyn M, Bergeron C, Klinkhamer P, et al. Liquid compared with conventional cervical cytology: a systematic review andmeta- analy- sis [ J ]. Obstet Gynecal, 2008,111 ( 1 ) : 167 - 77.

二级参考文献41

  • 1谢淑雯,黄少侬,邹如婵,陈丽琼.汕头市已婚育龄妇女生殖健康状况调查[J].广东医学,2005,26(7):988-989. 被引量:10
  • 2刘沛,陈启光.贝叶斯统计及其在诊断和筛检试验评价中的应用[J].中国卫生统计,2006,23(4):361-363. 被引量:13
  • 3LIZANO M,DE LA CHE,CARRILLO GA,et al.Distribution of HPV16 and 18 intratypic variants in normal cytology,intraepithelial lesions,and cervical cancer in a Mexican population[J].Gynecol Oncol,2006:19.
  • 4WRIGHT J D,LI J,GERHARD,et al.Human papillomavirus type and tobacco use as predictors of survival in early stage cervical carcinoma[J].Gynecol Oncol,2005,98(1):84-91.
  • 5MCLACHLIN C M.Human papillomavirus in cervical neoplasia.Role,risk factors,and implications[J].Clin Lab Med,2000,20(2):257-270.
  • 6CASTELLSAGUE X,DIAZ M,DE SANJOSE S,et al.Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors:implications for screening and prevention[J].Natl Cancer Inst,2006,98(5):303-315.
  • 7DELL G,GASTON K.Human papillomaviruses and their role in cervical cancer[J].Cell Mol Life Sci,2001,58(12-13):1923-1945.
  • 8JUNEJ A,SEHGAL A,MITRA A B,et al.A survey on risk factors associated with cervical cancer[J].Indian J Cancer,2003,40(1):15-22.
  • 9Horri I. Data management for toxicological studies [J]. Environ Health Perspect, 1994,102 ( 1 ) : 71-75.
  • 10Smith JS, Green J, Berrington de Gonzalez A, et al. Cervi- cal cancer and use of hormonal contraceptives:a system- atic review [ J ]. Lancet, 2003,361 (9364) : 1159-1167.

共引文献35

同被引文献65

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部